Specified Drug-use Survey of Leqvio for s.c. Injection.
The objective of this study is to evaluate the long-term safety of Leqvio in patients with familial hypercholesterolaemia or hypercholesterolaemia in post-marketing clinical practice
- EligibilityCriteria: Inclusion Criteria:  Patients who provided written informed consent to participate in this survey prior to the start of treatment with Leqvio. Patients who received treatment with Leqvio as per the package insert.  Exclusion Criteria:  Patients who received treatment with a formulation containing the same ingredients as Leqvio in the past. Patients participating in other interventional studies at the time of informed consent. Patients planning to participate in other interventional studies during this survey. - HealthyVolunteers: No - Gender: All - MinimumAge: 15 Years - StdAgeList: Child, Adult, Older Adult - StudyPopulation: Patients treated with inclisiran - SamplingMethod: Non-Probability Sample